Tomato juice saponin, esculeoside B ameliorates mice experimental dermatitis
Journal Title: Functional Foods in Health and Disease - Year 2018, Vol 8, Issue 4
Abstract
Background: Allergic diseases like atopic dermatitis have recently increased. A naturally occurring glycoside, Esculeoside B, has been identified as a major component in tomato juice from the can. Accordingly, the present study investigated the effects of esculeoside B on experimental dermatitis mice. Results: Oral treatment with 10 mg/kg of esculeoside B on the experimental dermatitis mice for 4 weeks significantly decreased the skin clinical score of 2.0 compared to the control score of 5.0. Furthermore, the scratch frequency of mice treated with esculeoside B was lower compared to the control group. Overall, the administration of esculeoside B significantly inhibited T lymphocyte proliferation and demonstrated a tendency to decrease in IL-4 production. For example, the 121.2 pg/ml in the control group decreased to 96.1 pg/ml. There was also a decrease in serum IgE levels from 928.0 ng/ml in the control group to 687.8 ng/ml. Conclusion: Our study is the first to demonstrate how tomato juice saponin or esculeoside B may ameliorate mice experimental dermatitis by the inhibition of T cell proliferation.
Effect of Kefir on Fusobacterium nucleatum Potentially Causing Intestinal Cancer
Fusobacterium nucleatum (ATCC 25586) is an obligate anaerob, gram negative, non-spore former, and pleomorphic bacillus that can cause brain, pleura, lung and liver diseases mainly in the mouth and teeth. It was also note...
Tomato juice saponin, esculeoside B ameliorates mice experimental dermatitis
Background: Allergic diseases like atopic dermatitis have recently increased. A naturally occurring glycoside, Esculeoside B, has been identified as a major component in tomato juice from the can. Accordingly, the presen...
Anti-cancer effect of EGCG and its mechanisms
Epidemiological analysis demonstrated there are negative correlation between green tea consumption and the risk of non-Hodgkin lymphoma1 and prostate cancer. Recent studies show (–)-epigallocatechin-3-O-gallate (EGCG), m...
European Health Claims for Small and Medium-Sized Companies – Utopian Dream or Future Reality?
Background: In December 2007, the European Regulation (EC) 1924/2006 on nutrition and health claims came into force. The European Union wanted to regulate the use of health claims on products. An online survey was carrie...
Targeting biofilm inhibition using Quercetin – Interaction with bacterial cell membrane and ROS mediated biofilm control
Background: Quercetin is an active nutraceutical ingredient widely distributed in foods, vegetables, fruits, and more. Quercetin is a versatile functional food with extensive protective effects against many infectious an...